Search results for "PULMONARY"

showing 10 items of 3030 documents

Airway neutrophilia in COPD is not associated with increased neutrophil survival

2006

Neutrophilic airway inflammation is a prominent feature of chronic obstructive pulmonary disease (COPD) and correlates with disease severity. The mechanisms that determine the extent of neutrophilia could involve increased influx or prolonged survival of neutrophils. The aim of the study was to assess whether neutrophil pro-survival mechanisms are increased in the airways of subjects with COPD owing to the presence of anti-apoptotic factors in the bronchial lining fluid. Induced sputum samples were collected from 20 subjects with stable COPD, 14 healthy smokers and 14 healthy controls. Quantification of apoptotic neutrophils was based on typical morphological cell changes. Anti-apoptotic, p…

AdultMalePulmonary and Respiratory MedicineNeutrophilsNeutrophileRespiratory SystemApoptosisInflammationGranulocyteNeutrophil ActivationPulmonary Disease Chronic ObstructiveForced Expiratory VolumeHumansMedicineAnnexin A5Cells CulturedAgedCOPDbusiness.industrySmokingRespiratory diseaseSputumMiddle AgedFlow Cytometrymedicine.diseaseNeutrophiliarespiratory tract diseasesmedicine.anatomical_structureCase-Control StudiesImmunologySputumFemalemedicine.symptomAirwaybusinessFollow-Up StudiesEuropean Respiratory Journal
researchProduct

First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: A quality of life directed phase II randomiz…

2009

Abstract Background Quality of life (QoL) has gained greater importance in the management of metastatic non-small-cell lung cancer due to the palliative nature of treatment. Docetaxel (DCT) and cisplatin (CDDP) doublet has been reported to be associated to a better QoL than the weekly vinorelbine (VNR) and CDDP regimen. Recently a newer more tolerated schedule of the VNR/CDDP regimen has been published and is widely employed in medical practice. The impact of these regimens on patients' QoL as well as symptoms control and type and grading chemo-related side-effects has been compared prospectically. Methods Patients received CDDP 75mg/m 2 plus DCT 75mg/m 2 on day 1 every weeks (arm A) or CDD…

AdultMalePulmonary and Respiratory MedicineOncologyCancer Researchmedicine.medical_specialtyLung NeoplasmsNeutropeniamedicine.medical_treatmentDocetaxelNeutropeniaVinblastineVinorelbineClinical ProtocolsQuality of lifeCarcinoma Non-Small-Cell LungInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLung cancerneoplasmsAgedChemotherapybusiness.industryAnemiaVinorelbineMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryRegimenOncologyDocetaxelDisease ProgressionQuality of LifeFemaleTaxoidsCisplatinbusinessFebrile neutropeniamedicine.drugLung Cancer
researchProduct

Lungscape: Resected Non–Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters

2014

INTRODUCTION: The Lungscape project was designed to address the impact of clinical, pathological, and molecular characteristics on outcome in resected non-small- cell lung cancer (NSCLC).MATERIALS AND METHODS: A decentralized biobank with fully annotated tissue samples was established. Selection criteria for participating centers included sufficient number of cases, tissue microarray building capability, and documented ethical approval. Patient selection was based on availability of comprehensive clinical data, radical resection between 2003 and 2009 with adequate follow-up, and adequate quantity and quality of formalin-fixed tissue.RESULTS: Fifteen centers contributed 2449 cases. The 5-yea…

AdultMalePulmonary and Respiratory MedicineOncologymedicine.medical_specialtyLung NeoplasmsMultivariate analysis10255 Clinic for Thoracic Surgery610 Medicine & healthNSCLCOutcome (game theory)Patients’ and pathological characteristicsYoung AdultCarcinoma Non-Small-Cell LungInternal medicinemedicineHumansPatients' and pathological characteristicsYoung adultLung cancerPathologicalAgedOutcomeAged 80 and overTNM stageTissue microarraybusiness.industryMiddle Agedmedicine.diseaseBiobankSurgeryTreatment OutcomeOncologyAnnotated Tissue2740 Pulmonary and Respiratory Medicine10032 Clinic for Oncology and Hematology2730 OncologyFemaleSurgerybusinessJournal of Thoracic Oncology
researchProduct

The Influence of the Primary Tumor on the Long-term Results of Pulmonary Metastasectomy for Metastatic Renal Cell Carcinoma

2011

OBJECTIVE To investigate one of the primary tumor (PT) on pulmonary metastasectomy (PM) for metastatic renal cell carcinoma (RCC) and to define prognostic factors. METHODS Retrospective review of patients with pulmonary metastases from RCC from January 1999 through December 2008 was performed. All patients underwent PM with curative intend. TNM-classification, tumor stage and PT grade, disease-free-interval (DFI) from nephrectomy to the diagnosis of metastasis, systemic chemotherapy before surgical intervention, surgical procedures, morbidity, mortality, and survival were investigated. RESULTS One-hundred seven consecutive patients (age 61.5 ± 9.6 years) underwent PM. Morbidity and mortalit…

AdultMalePulmonary and Respiratory MedicineOncologymedicine.medical_specialtyLung NeoplasmsTime Factorsmedicine.medical_treatmentUrologyKaplan-Meier EstimateNephrectomyRisk AssessmentRisk FactorsRenal cell carcinomaInternal medicinemedicineAdjuvant therapyHumansPneumonectomyCarcinoma Renal CellAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overUnivariate analysisProportional hazards modelbusiness.industryMortality rateMetastasectomyMiddle Agedmedicine.diseasePrimary tumorKidney NeoplasmsNeoadjuvant TherapyNephrectomyTreatment OutcomeChemotherapy AdjuvantLymphatic MetastasisMultivariate AnalysisFemaleSurgeryNeoplasm GradingMetastasectomyCardiology and Cardiovascular MedicinebusinessThe Thoracic and Cardiovascular Surgeon
researchProduct

Asthmatic Bronchial Epithelium Is More Susceptible to Oxidant-Induced Apoptosis

2002

Abnormal apoptotic mechanisms are associated with disease pathogenesis. Because the asthmatic bronchial epithelium is characteristically damaged with loss of columnar epithelial cells, we postulated that this is due to unscheduled apoptosis. Using an antibody directed toward the caspase cleavage product of poly(ADP-ribose) polymerase, immunohistochemistry applied to endobronchial biopsies showed higher levels of staining in the bronchial epithelium of subjects with asthma as compared with normal control subjects (% epithelial staining [median (range) = 10.5 (1.4-24.5) versus 0.4 (0.0-9.7)]; P < 0.001). Because we were unable to determine whether this difference was due to ongoing inflammati…

AdultMalePulmonary and Respiratory MedicinePathologymedicine.medical_specialtyCell Biology; Molecular Biology; Pulmonary and Respiratory MedicineBiopsyClinical BiochemistryCellApoptosisBronchiInflammationRespiratory MucosaBiologyIn vivomedicineHumansMolecular BiologyCells CulturedAgedTumor Necrosis Factor-alphaEpithelial CellsHydrogen PeroxideCell BiologyMiddle AgedFlow CytometryOxidantsAsthmaIn vitroStainingmedicine.anatomical_structureApoptosisbiology.proteinImmunohistochemistryFemalePoly(ADP-ribose) Polymerasesmedicine.symptomAntibodyAmerican Journal of Respiratory Cell and Molecular Biology
researchProduct

Oxygen Radical Production by Alveolar Inflammatory Cells in Idiopathic Pulmonary Fibrosis

1990

Idiopathic pulmonary fibrosis (IPF) is a chronic inflammatory interstitial lung disease characterized by the accumulation of alveolar macrophages (AMs) and neutrophils in the lower respiratory tract, parenchymal cell injury, and fibrosis of the alveolar structure. Reactive oxygen intermediates (ROI) are claimed to be a major cause of tissue damage in IPF; however, the source of ROI has not been unequivocally identified. AMs, as well as neutrophils, are capable of releasing these agents. The contributions of these possible sources are not known. To address this question, we evaluated the spontaneous and stimulated (PMA or zymosan) ROI release of total bronchoalveolar cells and isolated AMs i…

AdultMalePulmonary and Respiratory MedicinePathologymedicine.medical_specialtyFree RadicalsNeutrophilsPrednisolonePulmonary FibrosisCell CountInflammationchemistry.chemical_compoundIdiopathic pulmonary fibrosisFibrosismedicineHumansLungmedicine.diagnostic_testSuperoxide Dismutasebusiness.industryMacrophagesZymosanZymosanInterstitial lung diseaseMiddle Agedrespiratory systemmedicine.diseaserespiratory tract diseasesOxygenPulmonary Alveolimedicine.anatomical_structureBronchoalveolar lavagechemistryLuminescent MeasurementsImmunologyTetradecanoylphorbol AcetateFemalemedicine.symptombusinessBronchoalveolar Lavage FluidRespiratory tractAmerican Review of Respiratory Disease
researchProduct

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised…

2015

Elevated numbers of blood eosinophils are a risk factor for asthma exacerbations. Reslizumab is a humanised anti-interleukin 5 monoclonal antibody that disrupts eosinophil maturation and promotes programmed cell death. We aimed to assess the efficacy and safety of reslizumab in patients with inadequately controlled, moderate-to-severe asthma.We did two duplicate, multicentre, double-blind, parallel-group, randomised, placebo-controlled phase 3 trials. Both trials enrolled patients with asthma aged 12-75 years (from 128 clinical research centres in study 1 and 104 centres in study 2) from Asia, Australia, North America, South America, South Africa, and Europe, whose asthma was inadequately c…

AdultMalePulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyAsiaAntibodies Monoclonal HumanizedPlaceboLebrikizumablaw.inventionSouth Africachemistry.chemical_compoundDouble-Blind MethodRandomized controlled trialReslizumablawmedicineHumansAsthmaIntention-to-treat analysisbusiness.industryAustraliaMiddle AgedSouth Americamedicine.diseaseBenralizumabAsthmaEosinophilsEuropeClinical trialTreatment OutcomechemistryNorth AmericaFemalebusinessmedicine.drugThe Lancet Respiratory Medicine
researchProduct

Different prognosis in hospitalized patients with influenza one season after the pandemic H1N1 influenza of 2009-2010 in Spain

2013

Background The present report compares prognosis in hospitalized cases with the H1N1 pandemic virus in two seasons. Methods Two series of hospitalized patients with laboratory-confirmed H1N1 pandemic influenza have been compared: 813 in the season 2009–2010 and 707 in the season 2010–2011. A detailed history of variables preceding hospital admission and during hospitalization was obtained by interview and clinical charts. A combined endpoint of death admission to intensive care was used as outcome due to the low number of deaths. Logistic regression was applied in the analysis for adverse outcome. Results Patients of the second season had different characteristics than in the first one (old…

AdultMalePulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyCritical CarePrognosiPandemic H1N1 InfluenzaEpidemiologyHospitalized patientsGrip A (H1N1)Logistic regressionSepsisYoung AdultInfluenza A Virus H1N1 SubtypeIntensive carePart 5Influenza HumanPandemicmedicineHumansEpidemiologiaAgedRespiratory distressbusiness.industryPublic Health Environmental and Occupational HealthOdds ratioMiddle AgedPrognosismedicine.diseaseSurvival AnalysismortalityConfidence intervalHospitalizationTreatment OutcomeInfectious DiseasesSpainEmergency medicineOriginal ArticleFemaleprognosisinfluenzabusinessInfluenza and Other Respiratory Viruses
researchProduct

Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

2020

CF-COVID19-Spain Registry Group.

AdultMalePulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyPneumonia ViralPopulationDiseaseRisk AssessmentCystic fibrosisArticleCystic fibrosisBetacoronavirus03 medical and health sciencesCOVID-19 Testing0302 clinical medicinemedicineHumansRegistries030212 general & internal medicineMortalityeducationPandemicsRetrospective Studieseducation.field_of_studyClinical Laboratory Techniquesbusiness.industrySARS-CoV-2IncidenceIncidence (epidemiology)Mortality rateCOVID-19Retrospective cohort studymedicine.diseaseCoronavirus030228 respiratory systemSpainFemaleObservational studyCoronavirus InfectionsRisk assessmentbusiness
researchProduct

Monitoring changes in anti-tuberculosis treatment: associated factors determined at the time of diagnosis

2013

OBJECTIVES: To determine predictive factors for changes in standard anti-tuberculosis chemotherapy at the time of diagnosis. METHODS: A prospective study was performed among tuberculosis (TB) patients treated at specialised centres during 2008-2009. Treatment outcome was monitored per standard guidelines. Treatment was considered successful if the patient was cured or completed treatment. Factors associated with treatment modification were analysed at the bivariate and multivariate levels using logistic regression. RESULTS: A total of 427 patients were included in the study. The initial standard treatment regimen was retained for 249 patients (58.3%), extended to 9 months for 36 (8.4%) and …

AdultMalePulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyTime FactorsMultivariate analysisTuberculosisAntitubercular AgentsComorbiditySex FactorsDrug Resistance Multiple BacterialTuberculosis Multidrug-ResistantOdds RatioHumansTuberculosisMedicineProspective StudiesProspective cohort studyDrug Substitutionbusiness.industryStandard treatmentRemission InductionAge FactorsOdds ratioMiddle Agedmedicine.diseaseComorbidityRegimenLogistic ModelsTreatment OutcomeInfectious DiseasesSpainMultivariate AnalysisPractice Guidelines as TopicSputumDrug Therapy CombinationFemaleGuideline Adherencesense organsmedicine.symptombusinessThe International Journal of Tuberculosis and Lung Disease
researchProduct